Mouse and human postnatal and fetal organoid units (OUs) maintained in either short-term culture (2 weeks) or long-term culture (from 4 weeks up to 3 months) without adding exogenous growth factors were implanted in immunocompromised mice to form tissue-engineered small intestine (TESI) in vivo. Intestinal epithelial stem and neuronal progenitor cells were maintained in long-term OU cultures from both humans and mice without exogenous growth factors, and these cultures were successfully used to form TESI. This was enhanced with OUs derived from human fetal tissues. Organoid unit culture is different from enteroid culture, which is limited to epithelial cell growth and requires supplementation with R-Spondin, noggin and epidermal growth factor.
INTRODUCTION
Intestinal enteroid culture is useful in order to understand developmental epithelial processes of the intestine and to model disease (Yin et al., 2018; Zou et al., 2017) . However, because this model is exclusively composed of epithelium (Rookmaaker, Schutgens, Verhaar, & Clevers, 2015) , the contributions of adjacent mesenchymal elements, including intestinal subepithelial myofibroblasts, muscle, neurons and glia, to the developing epithelium are not demonstrated. Enteroids are thus dependent on growth factor support for maintenance of the stem cell niche in vitro, because they lack a mesenchymal component that might supply these factors in vivo (Barker, 2014; Barker et al., 2010; McCracken, Howell, Wells, & Spence, 2011; Sato et al., 2009 Sato et al., , 2011b Spence et al., 2011; Yui et al., 2012) . Specifically, intestinal crypts, single leucine-rich repeat- (Sato et al., 2009; Watson et al., 2014) .
Tissue-engineered small intestine (TESI), a potential therapy for short bowel syndrome, can be formed from organoid units (OUs), which contain multiple cell types in addition to epithelium (Barthel et al., 2012a; Evans, Flint, Somers, Eyden, & Potten, 1992; Grant et al., 2015; Grikscheit et al., 2004; Mooney, Organ, Vacanti, & Langer, 1994; Spurrier & Grikscheit, 2013) . Short bowel syndrome is an important cause of intestinal failure, in which there is an inability to digest and absorb adequate nutrients, water and electrolytes (DiBaise, Young, & Vanderhoof, 2004; Goulet et al., 2013) . Most commonly caused by intestinal resection required to treat congenital anomalies or surgical emergencies, such as necrotizing enterocolitis or volvulus, short bowel syndrome is associated with multiple complications and a high mortality (Demehri et al., 2015; Fallon et al., 2014; Experimental Physiology. 2018; 103:1633 -1644 wileyonlinelibrary.com/journal/eph Quirós-Tejeira et al., 2004; Squires et al., 2012; Wales et al., 2005) .
Intestinal transplantation, the definitive therapy for short bowel syndrome, is accompanied by the morbidity of prolonged immunosuppression in addition to low long-term survival rates (Ueno et al., 2013) . Therefore, we seek to maintain and transplant autologous stem/progenitor cells that might develop into TESI.
Immediate in vivo implantation of intestinal OUs during an initial emergency surgery may be impossible owing to blood loss, infection or physiological instability (Demehri et al., 2015; Moss et al., 2006) .
Furthermore, the need to expand tissue to replace lost intestine represents a significant roadblock for rapid use of autologous OUs in TESI. Sustained OU culture might provide a period of incubation or expansion before implantation, allowing the host to recover for transplantation and providing a greater quantity of starting material for the implant.
In order to function, TESI must include all the components of native intestine, including epithelium, muscle, blood vessels, lymphatics and enteric nerves. Recent reports of intestinal cultures generated from induced pluripotent stem cells (iPSCs) describe the presence of many necessary cell types. However, the enteric nervous system does not develop in this system (Watson et al., 2014) , although it can be supplemented by adding a second donor cell population (Schlieve et al., 2017; Workman et al., 2017) . Furthermore, iPSCs typically require exogenous growth factors and/or non-physiological small molecules, and the relative costs of personalized iPSC production are high. Thus,
OUs as a source of tissue have several potential advantages relative to iPSCs or enteroids: reduction of exogenous factor support, reduced costs and more physiological complexity in terms of available cell types.
We hypothesized that OUs composed of all native intestinal components, including stem cells and their niche, would expand in vitro without additional secreted factors. In this study, we sought to establish an in vitro OU system as a foundation for providing source material for TESI. We investigated whether mouse or human intestinal
OUs could be cultured short term (1-2 weeks) and long term (4 weeks to 3 months) and, upon implantation on a biodegradable polymer scaffold, proliferate and maintain the key components of native small intestine that will be required for future human therapies. abnormalities. This study conformed to the standards set by the Declaration of Helsinki, except for registration in a database.
METHODS

Ethical approval
Animals
The wild-type mice (C57BL/6J, 000664) and non-obese diabetic/severe combined immunodeficient gamma mice (NOD/SCID, 005557) are from the Jackson Laboratory (Bar Harbor, ME, USA). All strains except NOD/SCID were maintained on a C57BL6 background.
Water and regular feeding were provided.
Anaesthesia and animal preparation
The mouse was anaesthetized with 1-5% isoflurane in an induction box, followed by maintenance on a nose cone. After induction of general anaesthesia and before the start of surgery, the animal was given a single dose of ketoprofen (5 mg kg −1 S.C.). The animal was maintained on a water-circulating heating pad throughout surgery to prevent hypothermia. Ophthalmic ointment was applied topically to the corneal surfaces before surgery to prevent corneal drying. The hair over the surgical site was removed by clipping, and loose hair was removed using adhesive tape after clipping. The depilated area was disinfected with three alternating scrubs of chlorhexidine solution.
Anaesthetic depth was monitored by testing the animal's eye-blink response to stimulation of the medial canthus of the eye and by testing their response to tail or toe pinch. A lack of response indicated that the animal was adequately anaesthetized for the surgical procedure.
At the end of the experiment, mice were killed by CO 2 inhalation; 4% CO 2 was administered until the rodents were unconscious, then CO 2 was increased to 12% until the following was observed: lack of breathing, loss of blink response when eyes were touched, loss of toe pinch response, loss of pink colour or foot pads and lack of response to handling. Cervical dislocation was applied as a secondary method after CO 2 inhalation to ensure death.
Preparation of organoid units
As reported previously (Grant et al., 2015; Sala et al., 2011) 
Culture of OUs and quantification of OU size and survival rate
Twenty microlitres of the prepared OUs (7 × 10 4 to 13 × 10 4 cellular clusters) were mixed with an equal volume of reduced growth factor Matrigel (354230; Corning, Tewksbury, MA, USA) and plated on a 24-well plate to form a thin layer of OU Matrigel. Alternatively, 50 l of OUs (2 × 10 5 to 3 × 10 5 cellular clusters) were mixed with an equal volume reduced growth factor Matrigel and plated on a sixwell plate. The plates were incubated at 37 • C for 30 min to achieve solidification. DMEM containing 10% FBS, 1× NEAA, and 1× Antibiotic/Antimycotic were added, 1 ml to each well for the 24-well plates or 2 ml to each well for the six-well plates. The plates were incubated at 37 • C in air supplemented with 5% CO 2 overnight. The medium was changed every 2 days. An area at the bottom of each well was marked, and the number of OUs in that area was counted under a Leica microscope (DMI6000B). Survival rates were calculated using day 1 survival as the reference. Survival rates were calculated as:
(number of OUs each day/number of OUs on day 1) × 100%. Counting was carried out three times, each with three wells, yielding a total count of 1760 OUs. Student's unpaired t tests were performed using were expressed as the mean ± SD. P is a two-tailed value for both experiments.
Preparation of enteroid (crypt) culture and determination of survival rate
Following a procedure similar to established protocols (Almohazey et al., 2017; Sato et al., 2011a) , ileums were collected from 8-week-old mice and rinsed in cold PBS. Crypts were released by Ca 2+ chelation and shaking, then embedded in Matrigel droplets containing EGF (PeproTech, Rocky Hill, NJ, USA; 20 ng ml −1 ), noggin (R&D, Minneapolis, MN, USA; 100 ng ml −1 ) and R-Spondin1 (R&D; 500 ng ml −1 ). After enteroids were established, they were recovered from Matrigel and broken up with a needle for passaging.
Approximately 300 isolated crypts in 40 l volume were then replated in Matrigel without EGF, noggin or R-Spondin1 and cultured with DMEM with 10% FBS and 1× NEAA. The survival rate of enteroids was determined by the same method used for counting the OUs in culture.
All experiments were performed at least three times. 
RNA extraction and RT-qPCR
Embedding of OUs in agarose and section
Organoid units were harvested by gently collecting the Matrigel, transferred to a 15 ml tube, and centrifuged at 193g for 5 min in an Eppendorf centrifuge 5810R. The pellet was then embedded into 3% low melting agarose, which was fixed in 10% formalin overnight and then embedded in paraffin. Sections 5 m in thickness were cut for
Haematoxylin and Eosin (H&E) and immunofluorescent staining.
Implantation of cultured OUs
Organoid units for short-and long-term culture were harvested and loaded onto biodegradable scaffolds as described while maintaining 
Immunostaining
The following primary antibodies were used: choline acetyl- 
RESULTS
Cultured mouse intestinal OUs out-survived mouse epithelial enteroids without supplementation of secreted factors
In the absence of EGF, noggin and R-Spondin1, enteroids declined precipitously and did not survive after 3 days in culture (Figure 1a , blue dashed line; Figure 1e ), as is reported in the literature (Mahe et al., 2013; Sato et al., 2009) . In similar culture conditions, the survival rate of mouse small intestine OUs decreased gradually over time but was consistently higher than that for enteroids ( Figure 1a , red line). Unlike enteroids, during this 6 day period, OUs were found to double in size, from ∼80 m in diameter on day 1 to ∼160 m in diameter on day 6 (Figure 1b,c) . Sections of OUs stained for the epithelial cell marker ECadherin showed the polarized epithelial cells forming a hollow sphere (Figure 1d ).
Differentiated cells are present in cultured mouse OUs
We investigated the differentiation of epithelial lineages by wholemount immunostaining of mouse OUs. Differentiated enterocytes 
Tissue-engineered small intestine grows successfully from both short-term and long-term OU culture
Organoid units from short-term culture (2 weeks) and long-term culture (4 weeks) were implanted, by a similar implantation procedure as previously described These extended long-term cultured OUs were implanted, and TESI was harvested 4 weeks later (Figure 5h ). In all, 24/30 of these implants formed TESI, demonstrating that OUs maintain growth potential even after 3 months in culture.
Tissue-engineered small intestine grows from short-term culture of postnatal human small intestine OUs
We applied similar culture conditions to organoid units derived from postnatal human intestine specimens and again observed growth in culture (Figure 6a(i) ). Immunofluorescent staining showed that human OUs expressed the epithelial marker E-Cadherin (Figure 6a(v) ), and the epithelial cells were proliferative (Ki67; Figure 6a (ii)). Additionally,
enterocytes (iii), goblet cells (iv), enteroendocrine cells (v) and
Paneth cells (vi) were noted in the postnatal human cultured OUs (Figure 6a ). We then implanted the short-term cultured human
OUs into NOD/SCID mice. Tissue-engineered small intestine was successfully generated 4 weeks postimplantation, forming typical villus-and crypt-like structures (Figure 6b(i) ). We identified all four differentiated epithelial cell types in TESI, namely, enterocytes, goblet cells, enteroendocrine cells and Paneth cells, in addition to neural progenitors (p75 + /S100 − ) (Figure 6b(iii-vi) ). Immunofluorescent staining also revealed that both Tuj1-positive neurons and SMA-positive smooth muscle cells were human derived, because both cell types co-stained for the human-specific MHC class I tissue marker, 2-microglobulin ( 2-MG; Figure 6b (ii)).
Tissue-engineered small intestine forms from short-term culture of fetal human small intestine OUs
We implanted cultured human fetal intestine OUs to grow TESI.
Fetal OUs grown for 7 days formed luminal structures (Figure 7a (Figure 7b(v) ). Large ganglion-like structures containing neurons and glia were also found in close proximity to the epithelium (Figure 7b(vi) ).
We have also identified an intermediate cell type that co-expresses Mucin2 and matrix metalloproteinase 7 (MMP7; Figure 7b (vii)).
DISCUSSION
We have demonstrated successful in vitro maintenance of the intestinal stem cell niche without the addition of exogenous signalling molecules.
Several growth factors currently necessary for enteroid culture upregulate the canonical Wnt pathway. Wnt dysregulation is a known mechanism for intestinal malignancy (Krausova & Korinek, 2014) .
Limiting necessary growth factor support might be advantageous to negotiate regulatory approval for practical application of in vitro cell therapies. after emergency surgery. Human small intestine was collected as discarded surgical specimens, and the available region was usually the ileum because jejunal surgery is less frequent. Mouse small intestine, including ileum and jejunum but excluding duodenum or large intestine, was processed as the source for murine OUs. Previously specific regional markers were investigated by Grant et al. (2015) , and work on the regional identity of OUs/enteroids has so far indicated that the source region is correlated with aspects of the subsequent cellular or tissue growth. For donor regions of the gastrointestinal tract resulting in the growth of tissue-engineered intestine, and in fact for other organs, such as lung Speer et al., 2011; Spurrier, Speer, Hou, El-Nachef, & Grikscheit, 2015; Trecartin & Grikscheit, 2017; Trecartin et al., 2016) , regional identity is maintained; for example, growing regions of the stomach, antrum versus whole stomach results in growth only of the harvested and transplanted region.
Mesenchymal-epithelial interactions contribute to development and maintenance of the stem cell niche in vivo (Farin, Van Es, & Clevers, 2012; Hemers et al., 2005; Karlsson, Lindahl, Heath, & Betsholtz, 2000; Kosinski et al., 2010; Shyer, Huycke, Lee, Mahadevan, & Tabin, 2015) . Cross-talk between surrounding mesenchyme and epithelium regulates intestinal development through multiple signals, In our hands, OUs maintained in culture successfully generated human TESI that appeared similar to TESI derived from direct reimplantation of OUs, as we have performed previously (Barthel et al., 2012a, b; Grant et al., 2015; Grikscheit et al., 2004; Levin et al., 2013; Sala et al., 2011; Schlieve et al., 2017; Speer et al., 2011; Spurrier & Grikscheit, 2013) . Differentiated epithelial cell types were identified in the cultured OUs at both short-and long-term time points (Figure 2 ).
In addition, there were numerous mesenchymal cell types, including muscle, neuronal progenitors and differentiated neurons with various cellular identities, in addition to macrophages (Figure 3 ) identified in the in vitro cultures. This is in agreement with the data from previous studies of TESI, in which many of these cell types were confirmed to arise from labelled donor cells, including components of the enteric nervous system, blood vessels, smooth muscle and intestinal subepithelial myofibroblasts (Finkbeiner et al., 2015; Sala et al., 2011) .
Interestingly, although in an early study of TESI we identified SMA+ desmin − cells in the location of intestinal subepithelial myofibroblasts , we did not identify overlapping PDGFR-and -SMA overlap in our samples, as is seen in some studies of the intestine.
The niche in engineered intestine may or may not be the same as in embryonic development or indeed even in tissue homeostasis or damage repair states.
Tissue-engineered small intestine containing all of these epithelial and mesenchymal cell types was also successfully generated from cultured human fetal OUs. Given the excellent growth potential of fetal tissue in general, this is not unexpected. The structure of the TESI derived from short-term culture of human fetal OUs appears well organized, with two distinct layers of smooth muscle (Figure 7b Tissue-engineered intestine has previously demonstrated full function when it rescued Lewis rats from short bowel syndrome, along with remodelling after connection to luminal flow (Grikscheit et al., 2004) , with additional data derived in the mouse. In the mouse model, further evidence of function has been recorded in TESI that appears similar to the TESI generated in these experiments (Grant et al., 2015) . We did not recapitulate those detailed investigations but did confirm that key mesenchymal and epithelial components, including the cell types noted above in addition to SGLT1 and various components of the enteric nervous system, are present in acceptable locations, with future assays required to evaluate the function of these components fully. Tissueengineered intestine has been successfully generated from the direct 
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